Skip to main content
Now MHRA approved in the UK (10 August 2026). Foundayo is prescription only. We do not sell medicines, issue prescriptions or give personal medical advice.

BMI and Foundayo: check your number and what it actually means

Foundayo's UK licence is built around BMI thresholds, so here's a proper calculator, the exact MHRA criteria, and an honest explanation of what BMI does and doesn't tell you. Your number is a starting point for a conversation with a prescriber, never a verdict.

Interactive tool

The Frayo BMI calculator

Works in metric or imperial. Everything is calculated on your device; nothing you type is sent anywhere or stored.

BMI is weight in kilograms divided by height in metres squared. It's a screening measure for populations, not a diagnosis for individuals, which is why the result below talks about ranges and licences rather than judgements.

This tool is general information, not medical advice or a prescribing decision. Thresholds are lower for some ethnic backgrounds; see below.

Last verified: 12 August 2026

The exact UK criteria for Foundayo

The MHRA has licensed Foundayo, alongside a reduced-calorie diet and increased physical activity, for adults with:

  • a BMI of 30 or above (obesity), or
  • a BMI between 27 and 30 (overweight) plus at least one weight-related condition.

It's separately licensed to improve blood sugar control in adults with insufficiently controlled type 2 diabetes. Weight-related conditions that typically qualify in UK GLP-1 prescribing include type 2 diabetes, prediabetes, high blood pressure, abnormal cholesterol, obstructive sleep apnoea and cardiovascular disease. The prescriber's assessment, not a list on a website, is what decides your case; a proper consultation also screens the things a calculator never can, like your medical history, other medicines and the thyroid red flags.

Lower thresholds for some ethnic backgrounds

BMI underestimates health risk at a given weight for people from some ethnic backgrounds. UK NICE guidance uses lower thresholds for people of South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean family background, because conditions like type 2 diabetes develop at lower BMIs in these groups. In practice, thresholds around 2.5 points lower are used. If that's you, don't rule yourself out at a BMI of 28 or 29 without asking: raise it in your consultation, because a good prescriber will apply the adjusted thresholds.

What BMI genuinely can't tell you

Time for the honest bit. BMI is a blunt instrument: it can't tell muscle from fat, so a rugby player and an inactive person can share a number while having completely different health; it says nothing about where fat sits, and waist measurement often predicts risk better; and it was built from population averages, which is why it needs the ethnic adjustments above. None of that makes it useless. It's quick, free, consistent, and at population scale it tracks health outcomes well, which is why licences and guidelines are built on it. The sensible reading: treat your BMI as one signal that starts a conversation, alongside waist size, blood pressure, blood sugar and how you actually feel, and let a clinician put the picture together.

Helpful extras worth knowing

  • Waist check: as a rule of thumb, a waist over half your height suggests carrying risk around the middle, whatever your BMI says. A tape measure is the cheapest health tool you'll ever buy.
  • Your BMI moves, and so does eligibility maths. Prescribers assess you at the point of prescribing; ongoing treatment reviews are normal as your weight changes.
  • Travel insurance asks for BMI too. Medical screenings routinely ask current height and weight, and honesty matters because claims can be checked against records. Our travel guide covers it properly.
  • NHS BMI tools: the NHS BMI calculator includes the ethnic adjustments and links to NHS weight management support, which is free and worth knowing about whatever you decide on medication.
  • Beware quiz-only prescribing. A BMI typed into a form is not a consultation. Reputable providers verify identity and weight, review your history and give you a real clinician to talk to; that's part of how you spot the good ones.

Where this fits in your decision

Eligible on paper is step one of several. What the medicine is and what the trials showed is covered in our main guide, the honest side effect picture is on the side effects map, and when UK prices land they'll be on our retail and discount lists. Safety first, then eligibility, then price.

Nick Johnson Founder and healthcare pricing analyst, Medstack Ltd

Nick founded Monj, iGovy, Ogovy and Frayo to bring honest, checkout-price comparison and provider verification to the UK weight management medicine market. His background is in IT and data, not pharmacy, which is exactly why the sites stay independent: no provider can buy a ranking, and awkward findings get published. Read more about Frayo and the team.